The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Celiac Disease Treatment Market Be By 2030 Compared To Its 2026 Market Size?
The celiac disease treatment market size has shown significant expansion in recent years. Its valuation is set to climb from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate of 9.3%. The historical period’s growth can be linked to factors such as restricted pharmacological treatment alternatives, the primary reliance on gluten-free diet management, increasing rates of diagnosis, heightened awareness of autoimmune disorders, and improved availability of diagnostic testing.
The celiac disease treatment market is projected to experience robust expansion over the coming years. Its valuation is set to reach $1.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is primarily driven by the emergence of non-dietary therapeutic solutions, the broadening of enzyme and immunotherapy pipelines, an increase in the global incidence of celiac disease, enhanced diagnostic precision, and greater healthcare expenditure directed towards chronic autoimmune conditions. Key trends anticipated during this period encompass the wider acceptance of gluten-free dietary management, the evolving development of enzyme-based therapies, a heightened emphasis on early detection and screening, the diversification of nutritional supplement-based treatments, and improved patient understanding and disease education.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Which Key Factors Are Driving The Celiac Disease Treatment Market Growth?
The increasing occurrence of diabetes is projected to stimulate expansion within the celiac disease treatment market in the coming period. Diabetes is a long-term health condition characterized by the body’s impaired ability to manage blood sugar or glucose levels effectively. The growing incidence of diabetes stems from common dietary requirements, given that both diabetes and celiac disease necessitate strict regulation of food consumption to maintain blood sugar stability and avoid adverse outcomes. Treatment for celiac disease assists in diabetes management by advocating a gluten-free regimen, which can enhance general digestive well-being and nutrient uptake. This approach facilitates superior blood sugar regulation and minimizes complications for those dealing with both ailments. As an illustration, in June 2024, the National Health Service, a UK government body, reported that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes is fueling the expansion of the celiac disease treatment market.
How Is The Celiac Disease Treatment Market Organized By Segment Classification?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies
Which Trends Are Influencing Demand In The Celiac Disease Treatment Market?
Leading companies in the celiac disease treatment market are prioritizing the creation of oral treatments, specifically small molecule therapies. These therapies aim to offer precise relief by inhibiting immune reactions to gluten, boosting patient adherence, and providing alternatives to restrictive gluten-free diets. Small molecule therapies are minute drugs that easily penetrate cells to target and address disease-causing proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, introduced IMU-856. This small molecule elevates endogenous glucagon-like peptide-1 (GLP-1) levels, which contributes to better intestinal barrier function in celiac disease patients. It also enhances nutrient absorption and eases symptoms without suppressing immune activity.
Who Are The Industry Participants Involved In The Celiac Disease Treatment Market?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Get The Full Celiac Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Which Geographic Region Dominates The Celiac Disease Treatment Market?
North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Celiac Disease Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company
Constipation Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model